{
  "num_tested_probands": [
    1,
    5,
    1,
    0
  ],
  "num_positive_het_probands": [
    0,
    3,
    1,
    0
  ],
  "positive_phenotypes": [
    [
      "extensively prolonged neuromuscular block"
    ],
    [
      "prolonged duration of action of mivacurium",
      "zero BChE activity"
    ],
    [
      "prolonged duration of neuromuscular block",
      "absence of BChE activity"
    ],
    []
  ],
  "num_compound_or_double_hets": [
    1,
    1,
    1,
    0
  ],
  "quote_snippets": [
    [
      "This article presents the pharmacodynamics and phar-",
      "macokinetics of a normal dose of mivacurium in a patient",
      "The patient was compound heterozygous for silent mutations in the butyrylcholinesterase gene: The re-",
      "sponse to mivacurium was an extensively prolonged duration",
      "Complete nucleotide sequencing revealed two point mutations, the known silent variant S7 and a previously undescribed mutation of amino acid residue 170 introducing a stop codon:"
    ],
    [
      "the patient and one brother are homozygous for silent mu-",
      "tations, whereas the father; the mother; and the other brother are heterozygous for a silent mutation.",
      "the patient is compound heterozygous for two silent mutations.",
      "The patient's BChE activity was zero",
      "The case presented shows that patients  compound heterozygous for two silent mutations respond to miva-",
      "curium with extensively prolonged duration of action: The time to sufficient clinical recovery of neuromuscular function was 8 h after a normal intubation dosing:"
    ],
    [
      "Pedigree of the family with pheno-",
      "types and genotypes.",
      "Sequence analyses reveal (A) a normal sequence covering amino acid residue 115 with a single G nucleotide (arrow); (B) double peaks (G",
      "and A nucleotides; arrow) reveal heterozygous mutation G>A This muta-",
      "tion, GlylISASp, is present in the mother and the three sons (striped area): (C) Nor-",
      "mal sequence covering amino acid resi-",
      "due 172 with a single \u20ac nucleotide (ar-",
      "row): (D) Double peaks (C and T nucleotides; arrow) indicating heterozy-",
      "gous mutation; C->T This mutation (Gln172STOP) is present in the father and two sons (black area in the pedigree).",
      "DNA analysis revealed two point mutations, the known S7-variant 18 and an undescribed mutation; which introduced a stop codon at amino acid residue 172 of the 574 amino acid residues of normal BCHE.",
      "Biochemical data supported the conclusion that the patient was com-",
      "pound heterozygous for two silent mutations.",
      "The homozygous silent phenotype of BChE is charac-",
      "terized by complete absence of BChE activity Or by less than 10% activity of the usual phenotype. ",
      "Our results indicate that patients who are compound heterozygous for silent mutations in the BCHE respond t0 mivacurium by extensively prolonged duration of its action;"
    ],
    []
  ],
  "cleaned_quotes": [
    [
      "This article presents the pharmacodynamics and phar-",
      "macokinetics of a normal dose of mivacurium in a patient",
      "The patient was compound heterozygous for silent mutations in the butyrylcholinesterase gene. The re-",
      "sponse to mivacurium was an extensively prolonged duration",
      "Complete nucleotide sequencing revealed two point mutations, the known silent variant S7 and a previously undescribed mutation of amino acid residue 170 introducing a stop codon."
    ],
    [
      "the patient and one brother are homozygous for silent mu-",
      "tations, whereas the father, the mother, and the other brother are heterozygous for a silent mutation.",
      "the patient is compound heterozygous for two silent mutations.",
      "The patient's BChE activity was zero",
      "The case presented shows that patients compound heterozygous for two silent mutations respond to miva-",
      "curium with extensively prolonged duration of action: The time to sufficient clinical recovery of neuromuscular function was 8 h after a normal intubation dosing."
    ],
    [
      "Pedigree of the family with pheno-",
      "types and genotypes.",
      "Sequence analyses reveal (A) a normal sequence covering amino acid residue 115 with a single G nucleotide (arrow); (B) double peaks (G",
      "and A nucleotides; arrow) reveal heterozygous mutation G>A This muta-",
      "tion, GlylISASp, is present in the mother and the three sons (striped area): (C) Nor-",
      "mal sequence covering amino acid resi-",
      "due 172 with a single \u20ac nucleotide (ar-",
      "row): (D) Double peaks (C and T nucleotides; arrow) indicating heterozy-",
      "gous mutation; C->T This mutation (Gln172STOP) is present in the father and two sons (black area in the pedigree).",
      "DNA analysis revealed two point mutations, the known S7-variant 18 and an undescribed mutation; which introduced a stop codon at amino acid residue 172 of the 574 amino acid residues of normal BCHE.",
      "Biochemical data supported the conclusion that the patient was com-",
      "pound heterozygous for two silent mutations.",
      "The homozygous silent phenotype of BChE is charac-",
      "terized by complete absence of BChE activity Or by less than 10% activity of the usual phenotype. ",
      "Our results indicate that patients who are compound heterozygous for silent mutations in the BCHE respond to mivacurium by extensively prolonged duration of its action;"
    ],
    []
  ],
  "gene_symbol": [
    [
      "BCHE",
      "NES",
      "PC",
      "SI",
      "STH",
      "TAT"
    ],
    [
      "AGA",
      "AGT",
      "BCHE",
      "CAT",
      "GAA",
      "GC",
      "GCA",
      "PC",
      "SI",
      "TAT",
      "TG"
    ],
    [
      "AR",
      "BCHE",
      "CIT",
      "CRP",
      "GC",
      "NES",
      "PC",
      "SI",
      "STH",
      "TAT"
    ],
    [
      "BCHE",
      "CP",
      "NES",
      "SI",
      "STH"
    ]
  ],
  "genomic_hgvs": [
    [],
    [],
    [],
    []
  ],
  "explanation": {
    "num_tested_probands": [
      "The article focuses on the pharmacodynamics and pharmacokinetics of mivacurium in a single patient with phenotype SS.",
      "The report mentions testing the patient, his parents, and his two brothers, totaling five individuals.",
      "The report discusses only one proband with specific BChE mutations.",
      "The excerpt does not mention specific probands being tested."
    ],
    "num_positive_het_probands": [
      "The proband was not a positive HET for a pathogenic variant; the focus was on compound heterozygosity for silent mutations.",
      "The text notes that the father, the mother, and one brother are heterozygous for a silent mutation.",
      "The proband is identified as compound heterozygous for two mutations: Gly115Asp and Gln172STOP.",
      "The excerpt does not provide clear information on probands with heterozygous findings."
    ],
    "positive_phenotypes": [
      "The patient exhibited an extensively prolonged neuromuscular block, which is explicitly associated with compound heterozygosity in the study.",
      "The patient has zero BChE activity and an extremely prolonged duration of action of mivacurium.",
      "The proband exhibits phenotypic traits like prolonged duration of neuromuscular block and absence of BChE activity.",
      "No specific phenotypes associated with positive probands are mentioned in this excerpt."
    ],
    "num_compound_or_double_hets": [
      "The patient was identified as compound heterozygous for two silent mutations in the butyrylcholinesterase gene.",
      "The patient is specifically stated to be compound heterozygous for two silent mutations.",
      "The proband is described as compound heterozygous for silent mutations in the BCHE gene.",
      "The excerpt does not mention compound or double heterozygous mutations."
    ]
  }
}